NCT02604524COMPLETEDanonymous

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

Sponsor

Source record

Daniel Chernavvsky, MD, CRC

Phase

Source record

Modality

AI-normalized

medical device

Target

AI-normalized

Type 1 Diabetes Mellitus (T1DM)

Indication / condition

AI-normalized

Type 1 Diabetes Mellitus

Intervention

Source record

Closed-Loop Control, Sensor Augmented Pump Therapy

Related intelligence directories

Indication directory: Type 1 Diabetes Mellitus Modality directory: medical device Target directory: Type 1 Diabetes Mellitus (T1DM)

Source & freshness

Source record

NCT ID

NCT02604524

Original source

ClinicalTrials.gov

Source last updated

Sep 19, 2018

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT02604524

Title

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

Sponsor

Daniel Chernavvsky, MD, CRC

Status

COMPLETED

Phase

Condition raw

Type 1 Diabetes Mellitus

Condition normalized

Type 1 Diabetes Mellitus

Modality raw

Type 1 Diabetes Mellitus

Modality normalized

medical device

Target raw

Type 1 Diabetes Mellitus (T1DM)

Target normalized

Type 1 Diabetes Mellitus (T1DM)

Interventions

Closed-Loop Control, Sensor Augmented Pump Therapy

Public preview

Source record

This study evaluated the effectiveness of a Closed-Loop Control (CLC) system, also known as an Artificial Pancreas, in managing blood glucose levels during extended exercise in youth with T1DM. Conducted at a ski camp, the trial aimed to demonstrate the superiority of CLC over traditional Sensor-Augmented Pump (SAP) therapy.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT02604524

Status

COMPLETED

Phase

Sponsor

Daniel Chernavvsky, MD, CRC

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedSep 19, 2018

Internal syncJun 05, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02604524

Indication

Type 1 Diabetes Mellitus

Modality

medical device

Target

Type 1 Diabetes Mellitus (T1DM)

Intervention

Closed-Loop Control, Sensor Augmented Pump Therapy

Source record